Alpharmaxim in the press

With many organisations beginning to invest in behavioural science, we’ve been writing about the benefits for pharma companies. From optimising early drug design and development to addressing complex barriers to adoption in prescribing new drugs, we’ve been shouting about how you can improve the impact of your communications and achieve real change. Read on for our insights.

PharmaTimes Magazine cover story

Alive in ’25! Reflections and predictions – our luminaries look across the pharmaverse with conclusions and curiosity. Cover story in PharmaTimes Magazine

https://magazine.pharmatimes.com/collections/pharmatimes-december-2024/2c19218b-a8bc-11ef-8b79-42010a800017?fullscreen=false

Life Science Success podcast

IPI

Life Science Leader

Why behavioural science is needed on day one to support patient-focused drug development. Guest column in Life Science Leader

https://www.lifescienceleader.com/doc/why-behavioral-science-is-needed-on-day-one-to-support-patient-focused-drug-development-0001

PM360

Patient-focused drug development: identifying patient priorities

https://www.pm360online.com/guest-commentary-patient-focused-drug-development-identifying-patient-priorities/

The Pharma Letter

Patient-focused drug development: is behavioural science the answer to fully understanding patient priorities?

https://www.thepharmaletter.com/patient-focused-drug-development-is-behavioural-science-the-answer-to-fully-understanding-patient-priorities

Outsourcing Pharma

Incorporating behavioural science: A new approach to patient-focused drug development?

https://www.outsourcing-pharma.com/Article/2024/06/18/Is-behavioral-science-key-to-patient-focused-drug-development

Five quick questions

Five quick questions

https://www.linkedin.com/pulse/5qq-quick-questions-william-hind-ceo-alpharmaxim-healthcare-muniz-kgraf/?trackingId=rRPPi6EvpNVy7K4U2NvknA%3D%3D

PharmaPhorum

Behavioural science in biopharma: Convincing backers and physicians to support new drugs requires more than education

https://pharmaphorum.com/sales-marketing/behavioural-science-biopharma-convincing-backers-and-physicians-support-new-drugs

Journal of mHealth

Novel drugs: The case for applied behavioural science in driving take-up. Article in the Journal of mHealth

https://thejournalofmhealth.com/novel-drugs-the-case-for-applied-behavioural-science-in-driving-take-up/

 

Empowered patient

Unlocking the power of behavioural science for healthcare communications. Empowered Patient Podcast with Karen Jagoda

https://empoweredpatientradio.com/unlocking-the-power-of-behavioral-science-for-healthcare-communications-with-william-hind-alpharmaxim

LifeSciences360

Cell & Gene

The role of behavioural science in improving cell & gene therapy adoption. Guest column in cell & gene

https://www.cellandgene.com/doc/the-role-of-behavioral-science-in-improving-cell-gene-therapy-adoption-0001

PharmaTimes

Reality sights: Why behavioural science may hold the key to take up of next-generation therapies. Guest column in PharmaTimes Magazine

http://magazine.pharmatimes.com/#/reader/51518/257196

Healthcare Business Today

Patient-focused drug development: applying behavioral science from day one to understand patients’ real priorities

Talk to us about how we can transform your communications

Click here

Leave a Reply

Your email address will not be published. Required fields are marked *